Session Coverage
-
Thoracic oncology at CHEST 2026: Breaking down guidelines, AI, and gray zones for all experts
Sessions spanning lung cancer diagnosis, interventional pulmonology, and radiology will reflect the fast-moving field and the real-world questions clinicians face every day in practice, said Jose De Cardenas, MD, FCCP.
-
Boost procedural knowledge and skills during hands-on simulation sessions
Simulation courses during CHEST 2026 will empower clinicians to solve the problems they encounter in day-to-day practice using the latest procedural equipment and techniques.
-
Airways disease at CHEST 2026: Cutting-edge updates and controversies in COPD, bronchiectasis, asthma, and more
For clinicians who treat airways disease, CHEST 2026 will offer a guideline-driven curriculum built around what’s new, immediately applicable, and possibly even controversial, said Dharani K. Narendra, MD, FCCP.
-
Pulmonary vascular disease and cardiovascular medicine at CHEST 2026: PH, PE, CTEPH, HFpEF, and more
Sessions at CHEST 2026 will include talks on pulmonary hypertension (PH), pulmonary embolism (PE), chronic thromboembolic pulmonary hypertension (CTEPH), heart failure with preserved ejection fraction (HFpEF), and more, said Oksana Shlobin, MD, FCCP.
-
Dig into complex topics with sessions for advanced learners at CHEST 2026
At CHEST 2026, more than 120 “Advanced” sessions will meet mid- and late-career clinicians at their level, said Mauricio Danckers, MD, FCCP.
-
Kick-start your learning with CHEST 2026 premeeting courses
By arriving one day early to CHEST 2026, clinicians can immerse themselves in an educational experience unlike any other, said Allison Wynes, DNP, CCAPP, FCCP.
-
Critical care at CHEST 2026: POCUS, new sepsis guidelines in practice, neurocritical care, and more
Sessions at CHEST 2026 will challenge clinicians to rethink traditional techniques and explore new applications in critical care medicine, said Alice Gallo de Moraes, MD, FCCP.
-
ILD and lung transplant at CHEST 2026: New antifibrotic, community transplant management, SARD-ILD, and more
The CHEST 2026 program will include timely, practical content for clinicians who care for patients with interstitial lung disease (ILD) and those who have undergone lung transplantation, said Corey Kershaw, MD, FCCP.











